Medexus Pharmaceuticals (TSX:MDP) Current Accrued Expense : C$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Current Accrued Expense?

Medexus Pharmaceuticals's Current Accrued Expense for the quarter that ended in Dec. 2023 was C$0.0 Mil.

Medexus Pharmaceuticals's annual Current Accrued Expense increased from Mar. 2021 (C$15.7 Mil) to Mar. 2022 (C$21.7 Mil) and increased from Mar. 2022 (C$21.7 Mil) to Mar. 2023 (C$31.8 Mil).

Medexus Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Medexus Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Current Accrued Expense Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Current Accrued Expense

Get a 7-Day Free Trial

18.54

15.68

21.68

31.82

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															-	31.82	-	-	-

Medexus Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Medexus Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

MEDXF:USA P731:Germany

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Executives

Benoit Gravel

Director